AN ACT TO AMEND TITLES 18, 29, AND 31 OF THE DELAWARE CODE RELATING TO HEALTH INSURANCE.

Summary

The act obligates individual, group, state employee, and public‑assistance health policies to pay for biomarker tests that are medically necessary, as shown by FDA labeling, drug indications, CMS coverage determinations, or recognized clinical guidelines. It does not force coverage for screening or experimental tests, and it leaves room for usual cost‑sharing, provider restrictions, and utilization management. The requirements take effect for policies issued or changed after December 31, 2027.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share